← Back to Search

Cognitive Behavioural Therapy Training Tool for Psychosis (CBTpro Trial)

N/A
Waitlist Available
Led By Sarah Kopelovich, PhD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Over 18
Chart diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, bipolar or depressive disorder with psychotic features, brief psychotic disorder, other specified psychotic disorder, unspecified schizophrenia spectrum and other psychotic disorder.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0,3,6 months
Awards & highlights

CBTpro Trial Summary

This trial will develop and evaluate an AI-based training tool to support high-quality skills training in CBT for psychosis. The goal is to provide a rapid means of scaling and sustaining high-quality CBTp in routine care settings across the US.

Who is the study for?
This trial is for frontline clinical staff over 18 who treat adult outpatients with psychotic or major mood disorders at study sites. They must speak and read English well, work with enrolled providers, and can't have prior CBTp training or plan to leave their clinic within 6 months.Check my eligibility
What is being tested?
CBTpro, an AI-based tool for Cognitive Behavioral Therapy (CBT) training targeting psychosis, is being tested to improve the quality of CBT in routine care settings across the US by providing a scalable training solution.See study design
What are the potential side effects?
As this trial involves professional training rather than direct medical intervention, traditional side effects are not applicable. However, participants may experience stress or discomfort related to new technology adoption.

CBTpro Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 18 years old.
Select...
I have been diagnosed with a psychotic disorder.

CBTpro Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0,3,6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0,3,6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Syndrome
Secondary outcome measures
Change in Recovery Assessment Scale (RAS)
Change in WHO Disability Assessment Schedule 2.0 (WHODAS)

CBTpro Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CBTproExperimental Treatment1 Intervention
In addition to TAU, clinicians and clients receive the CBTpro training.
Group II: Treatment as Usual (TAU)Active Control1 Intervention
CBT for psychosis distance learning course.

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,738 Previous Clinical Trials
1,844,051 Total Patients Enrolled
2 Trials studying Psychosis
420 Patients Enrolled for Psychosis
National Institute of Mental Health (NIMH)NIH
2,783 Previous Clinical Trials
2,688,847 Total Patients Enrolled
46 Trials studying Psychosis
10,419 Patients Enrolled for Psychosis
Lyssn.io, Inc.Industry Sponsor
3 Previous Clinical Trials
2,257 Total Patients Enrolled

Media Library

CBTpro Clinical Trial Eligibility Overview. Trial Name: NCT05127837 — N/A
Psychosis Research Study Groups: Treatment as Usual (TAU), CBTpro
Psychosis Clinical Trial 2023: CBTpro Highlights & Side Effects. Trial Name: NCT05127837 — N/A
CBTpro 2023 Treatment Timeline for Medical Study. Trial Name: NCT05127837 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is geriatric participation allowed in this investigation?

"Eligible candidates for this study must be 18 years or older but younger than 100."

Answered by AI

How many health centers are participating in this research endeavor?

"Participants are being recruited from 10 different medical centres, including Seattle, Ellensburg and Goldendale. To alleviate any travel demands associated with this trial, it is recommended to select the closest location possible."

Answered by AI

Am I eligible to partake in this research endeavor?

"This clinical trial is searching for 300 people aged 18-100 who have been diagnosed with schizophrenia. The most important criteria are that participants must be frontline healthcare professionals, providing direct care to adult outpatients and managing caseloads that involve psychotic or mood disorders featuring psychosis symptoms."

Answered by AI

Is this trial currently recruiting participants?

"The data hosted on clinicaltrials.gov confirms that this medical trial is not presently recruiting any more candidates; the initial posting was August 1st 2022 and the most recent update occurred February 4th 2022. However, there are 2159 other studies accepting participants at the moment."

Answered by AI

Who else is applying?

What site did they apply to?
Valley Cities Behavioral Health Care
Frontier Behavioral Health
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
CBTpro: Scaling up CBT for Psychosis Using Simulated Patients and Spoken Language Technologies
Sarah Kopelovich 2022. "CBTpro: Scaling up CBT for Psychosis Using Simulated Patients and Spoken Language Technologies". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05127837.
~109 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top